Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon a-2b to a-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report-Reference-Cited by-同舟云学术

Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon a-2b to a-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report

Published:2012 Issue:4 Volume:55 Page:122-126
ISSN:1423-0100
Container-title:Intervirology
language:en
Short-container-title:Intervirology

Author:

Kawaoka Tomokazu,Hiraga Nobuhiko,Takahashi Shoichi,Takaki Shintaro,Tsuge Masataka,Nagaoki Yuko,Hashimoto Yoshimasa,Katamura Yoshio,Miki Daiki,Hiramatsu Akira,Waki Koji,Imamura Michio,Kawakami Yoshiiku,Aikata Hiroshi,Ochi Hidenori,Tashiro Hirotaka,Ohdan Hideki,Chayama Kazuaki

Publisher

S. Karger AG

Subject

Infectious Diseases,Virology

Reference37 articles.

1. Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy

2. Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C

3. Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-α2 therapy

4. Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials

5. Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation;Hepatology Research;2014-02-17